Incorporating Patient Preferences via Bayesian Decision Analysis
- 3 March 2021
- journal article
- editorial
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical Journal of the American Society of Nephrology
- Vol. 16 (4), 639-641
- https://doi.org/10.2215/cjn.12110720
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Bayesian Adaptive Clinical Trials for Anti-Infective Therapeutics During Epidemic OutbreaksPublished by MIT Press ,2020
- Physicians’ Perspectives on FDA Approval Standards and Off-label Drug MarketingJAMA Internal Medicine, 2019
- Is the FDA too conservative or too aggressive?: A Bayesian decision analysis of clinical trial designJournal of Econometrics, 2019
- Patient-centered clinical trialsDrug Discovery Today, 2018
- Use of Bayesian Decision Analysis to Minimize Harm in Patient-Centered Randomized Clinical Trials in OncologyJAMA Oncology, 2017
- Discussion: New directions for the FDA in the 21st centuryBiostatistics, 2017